|

Medical grade honey formulation (MGH) (L-Mesitran®) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Zuyderland Medisch Centrum1

Indications

  • High Risk Human Papillomavirus1
  • Cervical Intraepithelial Neoplasia-II1
  • Cancer1

Other1 trial

Effect of Honey For CIN II
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.